153 related articles for article (PubMed ID: 17909076)
1. Prediction of adverse outcomes in children with sickle cell anemia: a study of the Dallas Newborn Cohort.
Quinn CT; Lee NJ; Shull EP; Ahmad N; Rogers ZR; Buchanan GR
Blood; 2008 Jan; 111(2):544-8. PubMed ID: 17909076
[TBL] [Abstract][Full Text] [Related]
2. Prognostic significance of early vaso-occlusive complications in children with sickle cell anemia.
Quinn CT; Shull EP; Ahmad N; Lee NJ; Rogers ZR; Buchanan GR
Blood; 2007 Jan; 109(1):40-5. PubMed ID: 16940426
[TBL] [Abstract][Full Text] [Related]
3. Prediction of adverse outcomes in children with sickle cell disease.
Miller ST; Sleeper LA; Pegelow CH; Enos LE; Wang WC; Weiner SJ; Wethers DL; Smith J; Kinney TR
N Engl J Med; 2000 Jan; 342(2):83-9. PubMed ID: 10631276
[TBL] [Abstract][Full Text] [Related]
4. Early onset dactylitis associated with the occurrence of severe events in children with sickle cell anaemia. The Paediatric Cohort of Guadeloupe (1984-99).
Foucan L; Ekouevi D; Etienne-Julan M; Salmi LR; Diara JP;
Paediatr Perinat Epidemiol; 2006 Jan; 20(1):59-66. PubMed ID: 16420342
[TBL] [Abstract][Full Text] [Related]
5. Reticulocytosis and anemia are associated with an increased risk of death and stroke in the newborn cohort of the Cooperative Study of Sickle Cell Disease.
Meier ER; Wright EC; Miller JL
Am J Hematol; 2014 Sep; 89(9):904-6. PubMed ID: 24891147
[TBL] [Abstract][Full Text] [Related]
6. Clinical events in a large prospective cohort of children with sickle cell disease in Nagpur, India: evidence against a milder clinical phenotype in India.
Jain D; Arjunan A; Sarathi V; Jain H; Bhandarwar A; Vuga M; Krishnamurti L
Pediatr Blood Cancer; 2016 Oct; 63(10):1814-21. PubMed ID: 27279568
[TBL] [Abstract][Full Text] [Related]
7. Survival of children with sickle cell disease.
Quinn CT; Rogers ZR; Buchanan GR
Blood; 2004 Jun; 103(11):4023-7. PubMed ID: 14764527
[TBL] [Abstract][Full Text] [Related]
8. Impact of chronic transfusion on incidence of pain and acute chest syndrome during the Stroke Prevention Trial (STOP) in sickle-cell anemia.
Miller ST; Wright E; Abboud M; Berman B; Files B; Scher CD; Styles L; Adams RJ;
J Pediatr; 2001 Dec; 139(6):785-9. PubMed ID: 11743502
[TBL] [Abstract][Full Text] [Related]
9. Red blood cell transfusion to treat or prevent complications in sickle cell disease: an overview of Cochrane reviews.
Fortin PM; Hopewell S; Estcourt LJ
Cochrane Database Syst Rev; 2018 Aug; 8(8):CD012082. PubMed ID: 30067867
[TBL] [Abstract][Full Text] [Related]
10. Sickle cell disease clinical phenotypes in children from South-Western, Nigeria.
Adegoke SA; Adeodu OO; Adekile AD
Niger J Clin Pract; 2015; 18(1):95-101. PubMed ID: 25511352
[TBL] [Abstract][Full Text] [Related]
11. Acute chest syndrome in sickle cell disease: clinical presentation and course. Cooperative Study of Sickle Cell Disease.
Vichinsky EP; Styles LA; Colangelo LH; Wright EC; Castro O; Nickerson B
Blood; 1997 Mar; 89(5):1787-92. PubMed ID: 9057664
[TBL] [Abstract][Full Text] [Related]
12. Improved survival of children and adolescents with sickle cell disease.
Quinn CT; Rogers ZR; McCavit TL; Buchanan GR
Blood; 2010 Apr; 115(17):3447-52. PubMed ID: 20194891
[TBL] [Abstract][Full Text] [Related]
13. Impact of sickle cell disease on presentation and progression of paediatric HIV: a retrospective cohort study.
Ssenyondwa J; George PE; Carlos Bazo-Alvarez J; Mercedes R; Kanywa JB; Naturinda E; Wasswa PLM; Lubega J
Trop Med Int Health; 2020 Jul; 25(7):897-904. PubMed ID: 32329120
[TBL] [Abstract][Full Text] [Related]
14. Improvement of medical care in a cohort of newborns with sickle-cell disease in North Paris: impact of national guidelines.
Couque N; Girard D; Ducrocq R; Boizeau P; Haouari Z; Missud F; Holvoet L; Ithier G; Belloy M; Odièvre MH; Benemou M; Benhaim P; Retali B; Bensaid P; Monier B; Brousse V; Amira R; Orzechowski C; Lesprit E; Mangyanda L; Garrec N; Elion J; Alberti C; Baruchel A; Benkerrou M
Br J Haematol; 2016 Jun; 173(6):927-37. PubMed ID: 27062606
[TBL] [Abstract][Full Text] [Related]
15. Mortality in sickle cell disease: A population-based study in an aboriginal community in the Gudalur Valley, Nilgiris, Tamil Nadu, India.
Sheshadri V; Shabeer P; Santhirapala V; Jayaram A; Krishnamurti L; Menon N
Pediatr Blood Cancer; 2021 Mar; 68(3):e28875. PubMed ID: 33381914
[TBL] [Abstract][Full Text] [Related]
16. Safety of deep sedation in young children with sickle cell disease: a retrospective cohort study.
Belmont AP; Nossair F; Brambilla D; Friedman M; Boswinkel J; Bradford AB; Kwiatkowski JL
J Pediatr; 2015 May; 166(5):1226-32. PubMed ID: 25919732
[TBL] [Abstract][Full Text] [Related]
17. Mortality in sickle cell disease. Life expectancy and risk factors for early death.
Platt OS; Brambilla DJ; Rosse WF; Milner PF; Castro O; Steinberg MH; Klug PP
N Engl J Med; 1994 Jun; 330(23):1639-44. PubMed ID: 7993409
[TBL] [Abstract][Full Text] [Related]
18. Reticulocyte count is the most important predictor of acute cerebral ischemia and high-risk transcranial Doppler in a newborn cohort of 395 children with sickle cell anemia.
Belisário AR; Sales RR; Toledo NE; Muniz MB; Velloso-Rodrigues C; Silva CM; Viana MB
Ann Hematol; 2016 Oct; 95(11):1869-80. PubMed ID: 27520094
[TBL] [Abstract][Full Text] [Related]
19. Acute painful crises of sickle cell disease in Egyptian children: predictors of severity for a preventive strategy.
Al-Haggar M; Al-Marsafawy H; Abdel-Razek N; Al-Baz R; Mostafa AH
Int J Hematol; 2006 Apr; 83(3):224-8. PubMed ID: 16720552
[TBL] [Abstract][Full Text] [Related]
20. Utilization of TCD screening for primary stroke prevention in children with sickle cell disease.
Armstrong-Wells J; Grimes B; Sidney S; Kronish D; Shiboski SC; Adams RJ; Fullerton HJ
Neurology; 2009 Apr; 72(15):1316-21. PubMed ID: 19365052
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
